Otonomy Investors

24 investors on Angel Roster list Otonomy in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Otonomy can appear together.

Investors listed
24
With verified email
29%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 24 Otonomy investors

The most complete profiles first. Showing 24 of 24.

  • Brian HalakVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 61 more

    Verified email available

  • Jay LichterVerified

    Venture Capital, Investor · United States

    Series AAdvertisingHealth CareData IntegrationHospitals

    Portfolio: Talla, NanoNets, Node, Enlibrium and 58 more

    Verified email available

  • Kevin KinsellaVerified

    Venture Capital, Founder, Angel/Individual · United States

    Series AAdvertisingHealth CareData IntegrationHospitals

    Portfolio: Talla, NanoNets, Node, Enlibrium and 57 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • Eckard WeberVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • Jim BlairVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • Thomas CooperVerified

    Micro VC · United States

    Health CareWearablesTelecommunicationsHospitals

    Portfolio: Cardiac Dimensions, Cortica, Nina McLemore, Tarsus Pharmaceuticals and 26 more

    Verified email available

  • Derek Rapp

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Isaac Zike Ph.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Jay Schmelter

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Jesse Treu

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 55 more

    Contact details available

  • John McKearn

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Karen Spilizewski

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Nancy Hong, PhD

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 37 more

    Contact details available

  • Tom Melzer

    Venture Capital, Founder, Investor · United States

    Series BSeries AHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Eran Nadav

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Genoa Pharmaceuticals, Enlibrium, CardioDx, Alphabet Energy and 31 more

    Contact details available

  • Eric Sillman

    Venture Capital, Micro VC · United States

    Health CareTelecommunicationsHospitalsInvestment Management

    Portfolio: Cardiac Dimensions, Cortica, Nina McLemore, Tarsus Pharmaceuticals and 26 more

    Contact details available

  • Heather Preston

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedCredit Industry

    Portfolio: Karuna Therapeutics, Akouos, Carisma Therapeutics, Avalyn Pharma and 4 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Tony Natale

    Micro VC · United States

    Health CareTelecommunicationsHospitalsLife Science

    Portfolio: Cardiac Dimensions, Cortica, Nina McLemore, Tarsus Pharmaceuticals and 26 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Otonomy investors are on Angel Roster?

Angel Roster lists 24 Otonomy investors. 7 of them (29%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (13) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Otonomy investors invest in?

Among those that list a stage, the most common are Seed (9), Pre-Seed (4) and Series A (4).

Where are Otonomy investors based?

Most are based in the United States (19) and Hong Kong (2).

Which companies have Otonomy investors backed?

The most-backed portfolio companies among them are Neuros Medical (11), Lyric Pharmaceuticals (10), Avalyn Pharma (9), Genoa Pharmaceuticals (8) and InterVene (7).

How do I contact Otonomy investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.